BioPharma Resources

Drugs by condition

Drugs approved for hepatitis b

Brand-name prescription drugs and biologics whose FDA label lists hepatitis b as an approved use. Matched on the label phrases: "hepatitis B".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

9

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

6

New molecular entities and new biologics

In development

30

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for hepatitis b.

  • Hibsago (Bepirovirsen Sodium) · Glaxosmithkline NovelPriority reviewOct 20, 2026
  • Keytruda Qlex (Pembrolizumab, Berahyaluronidase Alfa-Pmph) · Merck Sharp Dohme NovelAccelerated approvalPriority reviewSep 19, 2025
  • Vemlidy (Tenofovir Alafenamide Fumarate) · Gilead Sciences INC Nov 10, 2016
  • Keytruda (Pembrolizumab) · Merck Sharp Dohme NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanSep 4, 2014
  • Viread (Tenofovir Disoproxil Fumarate) · Gilead Sciences INC Priority reviewOrphanJan 18, 2012

All approved drugs for hepatitis b, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 22 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Endoglycosidase (1)

  • Keytruda Qlex Pembrolizumab, Berahyaluronidase Alfa-Pmph · Merck Sharp Dohme · 2025

Programmed Death Receptor-1 Blocking Antibody (1)

  • Keytruda Pembrolizumab · Merck Sharp Dohme · 2014

Interferon alpha (1)

  • Pegasys Peginterferon Alfa-2a · Pharmaand Gmbh · 2002

Class not listed in FDA's data (6)

  • Hibsago Bepirovirsen Sodium · Glaxosmithkline · 2026
  • Baraclude Entecavir · Bristol Myers Squibb · 2005
  • Viread Tenofovir Disoproxil Fumarate · Gilead Sciences INC · 2001
  • Vemlidy Tenofovir Alafenamide Fumarate · Gilead Sciences INC · 2016
  • Viread Tenofovir Disoproxil Fumarate · Gilead Sciences INC · 2012
  • Baraclude Entecavir · Bristol Myers Squibb · 2005

Drugs in development for hepatitis b

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • ElebsiranVIR-2218, BRII-835Phase 38 trials

    Vir Biotechnology, Inc. · Viral Hepatitis, Hepatitis D, Chronic, Chronic Hepatitis B Virus (HBV) Infection

  • HydronidoneF351Phase 35 trials

    Beijing Continent Pharmaceutical Co, Ltd. · Liver Fibrosis, Chronic Hepatitis B With Hepatic Fibrosis, Liver Fibrosis in Chronic Hepatitis B

  • VIR-3434TobevibartPhase 35 trials

    Vir Biotechnology, Inc. · Viral Hepatitis, Hepatitis D, Chronic, Hepatitis B, Chronic

  • GST-HG141Phase 33 trials

    Fujian Akeylink Biotechnology Co., Ltd. · Chronic Hepatitis b, Chronic Hepatitis B

  • TAFPhase 33 trials

    Gilead Sciences · HIV-1-infection, Chronic Hepatitis B

  • TQA3605Phase 33 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis b, Chronic Hepatitis B, HBV Infection With LLV

  • HRS-5635Phase 32 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Chronic Hepatitis B, Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

  • LG Chem · Diphtheria, Tetanus, Pertussis

  • TDFPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection

  • BK1803Phase 31 trial

    Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus

  • GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial

    GC Biopharma Corp · Hepatitis B

  • UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials

    Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1

  • Peg-IFN-αpegylated interferonPhase 26 trials

    Brii Biosciences Limited · Chronic Hepatitis B, Chronic Hepatitis B Virus (HBV) Infection, Hepatitis B, Chronic

  • TVAX-008Phase 24 trials

    Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Chronic Hepatitis B, HBV Infection, Chronic Hepatitis B Virus

  • HT-101Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • HT-102Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • NAsNucleoside analogs, acidPhase 23 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B, HBV Infection With LLV

  • BRII-179Phase 22 trials

    Brii Biosciences Limited · Chronic Hepatitis B Virus (HBV) Infection, For Treatment of Chronic Hepatitis B Virus Infection

  • GST-HG131Phase 22 trials

    Fujian Akeylink Biotechnology Co., Ltd. · Chronic Hepatitis B

  • RBD1016Phase 22 trials

    Ribocure Pharmaceuticals AB · Chronic Hepatitis D, Chronic Hepatitis b

More on hepatitis b: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection · Fungal infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.